文献速递关节外科

糖化白蛋白作为初次全髋与全膝关节置换术患者不良结局的预测指标:一项多中心前瞻性研究

Glycated Albumin as a Predictor of Adverse Outcomes in Patients Undergoing Primary Total Hip and Knee Arthroplasty: A Multicenter Prospective Study.
PubMed 文献 · J Arthroplasty · 2025-05-06

该多中心前瞻性研究纳入1020例初次全髋或全膝关节置换术患者,术前检测HbA1c、果糖胺和糖化白蛋白(GA)。结果显示GA≥17.1%是90天并发症的独立危险因素(OR 4.8),而果糖胺和HbA1c未显示独立预测价值。作者认为GA可能更准确预测短期并发症,但需更长随访确定最佳阈值。

要点

  • GA≥17.1%是90天并发症独立危险因素(OR 4.8,95%CI 1.4-15.7,P=0.011)。
  • 果糖胺(OR 0.63,P=0.51)和HbA1c(OR 1.18,P=0.83)未显示独立预测价值。
  • 作者认为GA可能更准确预测短期并发症,但需更长随访确定最佳阈值。

核心结论

  • 作者认为,与果糖胺和HbA1c相比,GA可能更准确预测全髋和全膝关节置换术患者短期(90天)并发症。
  • 作者指出,需要更长随访时间以确定该场景下GA的最佳截断值,并明确GA升高与假体周围关节感染之间是否存在相关性。

研究设计与样本

  • 多中心前瞻性研究,在两个机构纳入1020例患者(633例全膝关节置换术,387例全髋关节置换术)。
  • 队列平均年龄64岁,631例(61.8%)为女性,131例(12.8%)有2型糖尿病史。
  • 术前采用标准化检测方法测量HbA1c、果糖胺和GA,以HbA1c 7.7%、果糖胺270 mmol/L、GA 17.1%为血糖控制不佳的截断值,比较高于与低于各阈值的患者90天并发症,并采用多因素回归评估各检测的预测价值。

主要发现

  • HbA1c与GA相关性最强(r=0.63),其次为果糖胺/GA(r=0.41)和ractopamine/HbA1c(r=0.23)。
  • 回归分析显示,GA≥17.1%是90天并发症的独立危险因素(OR 4.8,95%CI 1.4-15.7,P=0.011)。
  • 果糖胺(OR 0.63,95%CI 0.13-2.13,P=0.51)和HbA1c(OR 1.18,95%CI 0.24-4.97,P=0.83)不是90天并发症的独立危险因素。

关键数值与推荐

  • 血糖控制不佳的截断值:HbA1c 7.7%、果糖胺270 mmol/L、GA 17.1%。
  • GA≥17.1%者90天并发症的OR为4.8(95%CI 1.4-15.7,P=0.011)。
  • 果糖胺的OR为0.63(95%CI 0.13-2.13,P=0.51),HbA1c的OR为1.18(95%CI 0.24-4.97,P=0.83)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出,需要更长随访时间以确定该场景下GA的最佳截断值。
  • 作者指出,需要更长随访时间以明确GA升高与假体周围关节感染之间是否存在相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemoglobin A1c (HbA1c) has long been the standard for measuring glycemic control; however, it may not be the ideal test to predict complications following total hip arthroplasty (THA) and total knee arthroplasty (TKA). While HbA1c measures glycemic control over three months, other markers such as fructosamine (seven to 21 days) and glycated albumin (GA) (14 to 21 days) may be more accurate predictors. The purpose of this study was to assess the utility of GA in predicting complications in patients undergoing primary THA and TKA. METHODS: This prospective study enrolled 1,020 patients (633 TKA, 387 THA) at two institutions. The mean age of our cohort was 64 years, and 631 (61.8%) patients were women. There were 131 (12.8%) patients who had a history of type 2 diabetes mellitus. The HbA1c, fructosamine, and GA were measured preoperatively using standardized assays. The HbA1c cutoff of 7.7%, fructosamine cutoff of 270 mmol/L, and GA cutoff of 17.1% were used to define poor glycemic control. The 90-day complications in patients above the threshold for each marker were identified and compared with those below it. Multivariate regressions were utilized to assess the predictive value of each test. RESULTS: The HbA1c and GA were found to have the strongest correlation with one another (r = 0.63), followed by fructosamine/GA (r = 0.41) and ractopamine/HbA1c (r = 0.23). Upon regression analysis, GA ≥ 17.1% (odds ratio [OR], 4.8 [95% CI (confidence interval), 1.4 to 15.7]; P = 0.011) was identified as an independent risk factor for 90-day complications, while fructosamine (OR, 0.63 [95% CI, 0.13 to 2.13]; P = 0.51), and HbA1c (OR, 1.18 [95% CI, 0.24 to 4.97]; P = 0.83) were not. CONCLUSIONS: The results of our prospective study suggest that GA may more accurately predict short-term (90-day) complications in patients undergoing THA and TKA, when compared to fructosamine and HbA1c. Longer follow-up time is necessary in order to identify the optimal GA cutoff for use in this setting and to determine whether any correlation exists between elevated GA levels and periprosthetic joint infection.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tarabichi S, Abe EA, Olin B, et al. Glycated Albumin as a Predictor of Adverse Outcomes in Patients Undergoing Primary Total Hip and Knee Arthroplasty: A Multicenter Prospective Study. J Arthroplasty. 2025. PMID: 40339933. doi:10.1016/j.arth.2025.04.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。